Member access

4-Traders Homepage  >  Shares  >  Nyse  >  St. Jude Medical, Inc.    STJ   US7908491035

SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisionsForum 
Income Statement Evolution
St. Jude Medical, Inc. : Income Statement Evolution
Annual Income Statement Data
Actuals in M $ Estimates in M $
Fiscal Period December 201020112012201320142015
Sales5 1655 6125 5035 4075 5815 773
Operating income (EBITDA)1 6251 6221 7751 7161 7931 864
Operating profit (EBIT)1 3811 3261 4911 4291 5051 577
Pre-Tax Profit (EBT)--1 005---
Net income9078647529941 1211 201
EPS ( $)2,752,642,393,503,904,22
Dividend per Share ( $)-0,840,920,991,031,12
Yield-1,79%1,96%2,10%2,18%2,39%
Announcement Date01/26/2011
12:30pm
01/25/2012
12:30pm
01/23/2013
12:30pm
---
Finances - Leverage
St. Jude Medical, Inc. : Finances - Leverage
Actuals in M $ Estimates in M $
Fiscal Period December 201020112012201320142015
Debt2 0111 8111 8861 7581 171503
Finance------
Operating income (EBITDA)1 6251 6221 7751 7161 7931 864
Leverage
(Debt/EBITDA)
1,24x1,12x1,06x1,02x0,65x0,27x
Capital Expenditure305306280303309311
Book Value Per Share (BVPS)13,3 $14,0 $13,9 $15,1 $17,4 $20,1 $
Cash Flow per Share3,86 $3,93 $4,24 $3,68 $4,60 $5,54 $
Announcement Date01/26/2011
12:30pm
01/25/2012
12:30pm
01/23/2013
12:30pm
---
Balance Sheet Analysis
St. Jude Medical, Inc. : Balance Sheet Analysis
Assessed data source :
© 2013 Thomson Reuters
Advertisement
Financial Ratios

Size 2013e 2014e
Capitalization 13 318 M$ -
Company Value 15 076 M$ 14 489 M$
Valuation 2013e 2014e
PER (Price / EPS) 13,4x 12,1x
Capitalization / Revenue 2,46x 2,39x
EV / Revenue 2,79x 2,60x
EV / EBITDA 8,79x 8,08x
Yield (DPS / Price) 2,10% 2,18%
Profitability 2013e 2014e
Operating Margin (EBIT / Sales) 26,4% 27,0%
operating laverage (Delta EBIT / Delta Sales) -2,40x 1,66x
Net Margin (Net Profit / Revenue) 18,4% 20,1%
ROA (Net Profit / Asset) 11,6% 12,0%
ROE (Net Profit / Equities) 24,2% 23,4%
Rate of Dividend 28,2% 26,3%
Balance Sheet Analysis 2013e 2014e
CAPEX / Sales   5,61% 5,53%
Cash Flow / Sales (Taux d'autofinancement) 19,3% 23,3%
Capital Intensity (Assets / Sales) 1,58x 1,67x
Financial Leverage (Net Debt / EBITDA) 1,02x 0,65x
Price Earning Ratio
St. Jude Medical, Inc. : Price Earning Ratio
EPS & Dividend
St. Jude Medical, Inc. : EPS Dividend
Dynamic quotes  
ON
| OFF
Copyright © 2013 Surperformance. All rights reserved.